Design of New Potent, Selective, and Long-Acting NOP Receptor Agonists through Multiple Sequential d -Amino Acid Substitutions of [Arg14 Lys15]N/OFQ(1–15)-NH2
Journal of Medicinal Chemistry · 2026
DOI: 10.1021/acs.jmedchem.6c01281 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Chiara Sturaro und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience and Rehabilitation, University of Ferrara, Via Luigi Borsari 46, Ferrara44121, Italy. Hauptthemen laut MEDLINE: Receptors, Opioid, Drug Design, Amino Acid Substitution. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Recovery and Resilience Plan (NRRP), Mission 04 Component 2 Investment 1.5?NextGenerationEU, University of Padova, University of Ferrara.
Abstract (Originalsprache)
The nociceptin/orphanin FQ (N/OFQ) receptor (NOP) ligands are drug candidates for different diseases, but peptide ligands are often limited by rapid enzymatic degradation and short in vivo duration of action. Here, we applied a multiple D-amino acid substitution strategy to the peptide template [Arg14 Lys15]N/OFQ(1-15)-NH2 to improve metabolic stability while preserving receptor activity. Progressive substitutions revealed marked positional tolerance within the C-terminal address domain and identified [d-Lys13,15d-Arg14]N/OFQ(1–15)-NH2 (compound 1c) as the most promising compound. This led to the Cha1-containing analogue 3a, which retained full agonist efficacy and high selectivity at the NOP receptor in vitro and ex vivo. In vivo, compound 3a induced a long-lasting loss of the righting reflex in mice, closely overlapping the pharmacological profile of the potent and long-acting agonist UFP-112. These findings define the stereochemical tolerance of the NOP receptor toward multiple d-amino acid substitutions within the N/OFQ peptide and demonstrate that this information can be exploited as a rational design strategy to generate NOP receptor agonists with prolonged in vivo activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience and Rehabilitation, University of Ferrara, Via Luigi Borsari 46, Ferrara44121, Italy.
- Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via Luigi Borsari 46, Ferrara44121, Italy.
- Department of Pharmaceutical and Pharmacological Sciences, Section of Pharmacology, University of Padova, Largo Meneghetti, 2, Padova35131, Italy.
- Technopole of Ferrara, Laboratory for Advanced Therapies (LTTA), Via Fossato di Mortara 70, Ferrara44121, Italy.
ORCID-Profile: Federica Agosta, Antonella Ciancetta, Delia Preti, Salvatore Pacifico, Valentina Albanese, Giulio Meneguzzo, Davide Malfacini, Chiara Ruzza
Förderung
- National Recovery and Resilience Plan (NRRP), Mission 04 Component 2 Investment 1.5?NextGenerationEU
- University of Padova
- University of Ferrara
- ItelPharma
- Italian Ministry of University
Zitieren
APA
Sturaro, C., Rizzo, A., Morrone, E., Marzola, E., Pola, P., Frezza, A., Argentieri, M., Agosta, F., Ciancetta, A., Preti, D., Pacifico, S., Albanese, V., Meneguzzo, G., Malfacini, D., Ruzza, C., Calò, G., & Guerrini, R. (2026). Design of New Potent, Selective, and Long-Acting NOP Receptor Agonists through Multiple Sequential d -Amino Acid Substitutions of [Arg14 Lys15]N/OFQ(1–15)-NH2. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c01281
Vancouver
Sturaro C, Rizzo A, Morrone E, Marzola E, Pola P, Frezza A, et al. Design of New Potent, Selective, and Long-Acting NOP Receptor Agonists through Multiple Sequential d -Amino Acid Substitutions of [Arg14 Lys15]N/OFQ(1–15)-NH2. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.6c01281
BibTeX
@article{Sturaro2026,
author = {Sturaro, Chiara and Rizzo, Alessandra and Morrone, Erika and Marzola, Erika and Pola, Pietro and Frezza, Alessia and Argentieri, Michela and Agosta, Federica and Ciancetta, Antonella and Preti, Delia and Pacifico, Salvatore and Albanese, Valentina and Meneguzzo, Giulio and Malfacini, Davide and Ruzza, Chiara and Calò, Girolamo and Guerrini, Remo},
title = {Design of New Potent, Selective, and Long-Acting NOP Receptor Agonists through Multiple Sequential d -Amino Acid Substitutions of [Arg14 Lys15]N/OFQ(1–15)-NH2},
journal = {Journal of Medicinal Chemistry},
year = {2026},
doi = {10.1021/acs.jmedchem.6c01281}
}
EUVIMED